Produce and Evaluate an Evidence-based Health Awareness Video(HAV-RID)NCT07248319
Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases (HAV-RID Study)
A study testing Health awareness video on precautionary measures against respiratory infectious disease in people with Produce and Evaluate an Evidence-based Health Awareness Video, run by Lebanese American University at 1 site in Lebanon.
Trial summary
Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs). The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against respiratory infectious diseases among public transportation drivers in Lebanon. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Produce and Evaluate an Evidence-based Health Awareness Video
- What is being tested?
- Health awareness video on precautionary measures against respiratory infectious disease
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteLebanon
- Study dates
- 1 Mar 2026to 1 Mar 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Public transportation drivers who operate within the Lebanese public transportation system, regardless of their nationality or gender.
Who cannot join
- Commercial drivers (trucks) or others who are not in a daily contact with commuters.
- Drivers who are unwilling to enroll in the study or unable to comprehend written/verbal Arabic language will be excluded.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Lebanon1 site
Mahmoud Salam
Beirut
Mahmoud Salam, PhD, +96170054397, mahmoud.salam@lau.edu.lb
Mira Hassan, BSN, 0096181634805, mira.hassan02@lau.edu
About this study
Official title: Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases: A Randomized Controlled Trial on Public Transportation Drivers in Lebanon (HAV-RID Study)
Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs). The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against respiratory infectious diseases among public transportation drivers in Lebanon. You will be asked to watch a newly produced health-awareness video, then we will test your knowledge about respiratory infectious diseases , health-risk perceptions, attitude towards vaccination, and cognitive dissonance. Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. The experimental group (n=80) will watch a health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry/analyses. An incentive will be provided.
Read the detailed description
Background: Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs), elevating health-risk perceptions, and enhancing attitudes towards precautionary measures, as per the Health Belief Model (HBM) and Cognitive Dissonance Theory (CDT).
Aim: The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against RID among public transportation drivers in Lebanon.
Methods: This project will be conducted over three stages and executed over two fiscal years (start date March 2026).
Stage one: Drafting the script of the video is inspired by seven published / unpublished evidence-based studies on public transportation drivers in Lebanon and fourteen studies from international literature. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers.
Stage two: Using a Delphi technique, the script will be revised by a panel of eight experts in public health, infection control, psychology, filmmaking, and public transportation using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. A purposive sampling method will be followed. Once consensus is reached, the video will be produced.
Stage three: Non-blinded, randomized, two-arm controlled trial will be conducted by a group of senior nursing students (minimal risk study). Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. Simple randomization technique will be performed. The experimental group (n=80) will watch the health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry/analyses. An incentive will be provided.
Data analysis: Data will be analyzed using SPSS; IBM (version 30). Knowledge statements will be scored and converted to percentage mean score. Risk perceptions, attitude and dissonance will be scored and converted to mean scores. Between group analyses of mean differences will be tested using student t-test and one way analysis of variance (ANOVA) with post hoc analysis (for normally distributed data) and Kruskall Wallis test with post hoc analysis (for skewed data). Forward stepwise linear regression analyses will be executed. Statistical significance will be at P<0.05 (two sided). Interim analysis will be performed at n=40.
Expected outcomes: Public transportation drivers and users might be unknowingly exposed to RID, so promoting their safety is a priority. When public transportation drivers are exposed to a video on RID, they will gain knowledge about it and demonstrate a positive attitude towards precautionary measures. This video contributes to higher service satisfaction and subsequently higher utilization of the transportation system. Utilizing the public transportation systems reduces street congestions, controls pollution, saves money for users and generates profits for stakeholders. Promoting a safe public transportation system reflects positively on public health, aligns with the CDC mission to control the global spread of diseases and lessens disease burden. Last but not least, health awareness videos are cost effective and they can reach a wider audience.
Ethical considerations: This study will not pose any risk or harm to participants. The video will not contain any material that might offend, insult, degrade, or discriminate against study participants in any way possible. Medical jargon and complex terms will be avoided. The video will be concluded with contact information in case participants decided to consult with experts in the future. Data collectors will be trained on how to remedy their concerns through cognitive behavioral therapy techniques to resolve negative thoughts, guide them on sources of knowledge and places to obtain facemasks, hand sanitizers and vaccines. Last but not least, participants will not be asked for any ID. The decision to participate or not will have no impact on drivers.
- Being tested
- Health awareness video on precautionary measures against respiratory infectious disease
- Keywords
- influenza, covid-19, transportation, health awareness video, Lebanon
- Medical subject headings
- Influenza, Human, COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health awareness video on precautionary measures against respiratory infectious diseaseOther
Drafting of a narrative blueprint of the script for the health-awareness video is inspired by published and unpublished evidence-based studies previously conducted on public transportation drivers in Lebanon. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced.
| Study group | Role | What they receive |
|---|---|---|
| Experimental group (n=80) will watch the health-awareness video | Experimental | The experimental group will watch the newly produced health-awareness video. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced. Receives: Other: Health awareness video on precautionary measures against respiratory infectious disease |
| control group will watch a neutral video | Active comparator | control group will watch a neutral video (raising awareness about traffic signs in Lebanon, https://www.youtube.com/watch?v=hb3107sylj0 ) Receives: Other: Health awareness video on precautionary measures against respiratory infectious disease |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge
Knowledge about RID mode of transmission and prevention will be evaluated (Khoury and Salameh 2015, Choucair, El Sawda et al. 2021). The percentage mean of knowledge scores (PMS±SD) will be presented. Higher scores indicate better knowledge. This variable measures the effectiveness of the health awareness video.
Measured: 2 months
Patient Education Materials Assessment Tool - Audiovisual (PEMAT-AV) and • DISCERN tool
PEMAT-AV systematically evaluates the understandability and actionability of educational materials. Understandability is the viewers' ability to understand the video regardless of their diverse backgrounds and varying levels of health literacy. Actionability is the viewers' ability to identify what they can do based on the information presented in the video regardless of their background and level of health literacy. PEMAT produces separate numeric scores for understandability and actionability.
DISCERN: to enable information providers to judge the quality of information about treatment choices. DISCERN facilitates the production of new, high quality, and evidence-based consumer health information. DISCERN became a reliable and valid instrument for judging the quality of written consumer health information.
Measured: 5 months
Health-risk perceptions
Health-risk perceptions: participants' health-risk perceptions will be evaluated following two dimensions of the HBM that are the perceived susceptibility (2 items) and the perceived severity of RID (3 items) (Adams, Hall et al. 2014).
Measured: 2 months
Attitude towards vaccination
participants' attitude towards vaccination will be evaluated using three domains of the Vaccination Attitudes Examination (VAX) scale: unexplored side effects of the vaccines (5 statements), pharmaceutical companies profiteering from vaccines (3 statements), and preferred reliance on natural immunity (3 statements). VAX is a generic tool that identifies people with negative attitudes towards vaccines (Martin and Petrie 2017).
Measured: 2 months
Cognitive dissonance
dissonance is a self-reported measure of the emotional discomfort experienced due to cognitive dissonance (Elliot and Devine 1994). Cognitive dissonance can be measured using the dissonance thermometer that constitutes of adjectives distributed across four indices (discomfort index, negative self-index, shame index, and positive index). All four subscales demonstrated acceptable levels of reliability, with the positive and negative affect scales exhibiting excellent internal consistency and test-retest reliability (McGrath 2011). For this study, the discomfort index that constitutes of uncomfortable, uneasy, and bothered feelings will be used as adjective ratings (0 to 6). Higher score indicates an increased level of discomfort due to the effect of the video content.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Nov 2025
- Study start1 Mar 2026 (estimated)
- Primary completion1 Mar 2027 (estimated)
- Study completion1 Mar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Produce and Evaluate an Evidence-based Health Awareness VideoStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- After the video is produced, a non-blinded, randomized, two-arm controlled trial will be conducted. The experimental group will watch the newly produced health-awareness video, whereas the control group will watch a neutral video (raising awareness about traffic signs in Lebanon, https://www.youtube.com/watch?v=hb3107sylj0 ). The participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated.
- Masking
- None (open label)
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lebanese American University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mahmoud Salam, Lebanese American University
- Investigators
- Mahmoud Salam, PhD, Principal investigator, Lebanese American University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07248319
- Sponsor's protocol ID
- LAU.SON.MS1.18/Dec/2025
- Acronym
- (HAV-RID)
- Status last verified
- Nov 2025
- First submitted
- 18 Nov 2025
- Last updated
- 25 Nov 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Sharing of IPD will follow local policies and regulations.
Publications
Risk perceptions towards respiratory infectious diseases among university students utilizing the public transportation system in Lebanon
Salam M, Haidar GH. Influenza vaccine hesitancy and its determinants among Lebanese public transportation drivers. Vaccine X. 2024 Dec 25;22:100606. doi: 10.1016/j.jvacx.2024.100606. eCollection 2025 Jan.
PubMed 39845631Salam M, Honein-AbouHaidar G, Abdulrahim S. Exploring the challenges that public transportation drivers face in Lebanon. Work. 2026 Aug 21:10519815261476676. doi: 10.1177/10519815261476676. Online ahead of print.
PubMed 42627643COVID-19 risk perceptions among public transportation drivers and users in Lebanon: A cross-sectional study
Salam M, El Dhaybe S, Ghannam L, Serhan M, Hassan M. Production of a Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases for Public Transportation Drivers: Protocol for a Scoping Review, a Delphi Study, and a Randomized Controlled Trial. JMIR Res Protoc. 2026 Jun 19;15:e89474. doi: 10.2196/89474.
PubMed 42324927
Study at a glance
From the registry record, last updated by the sponsor on 25 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases: A Randomized Controlled Trial on Public Transportation Drivers in Lebanon (HAV-RID Study)
- ClinicalTrials.gov ID
- NCT07248319
- Acronym / sponsor ID
- (HAV-RID) / LAU.SON.MS1.18/Dec/2025
- Keywords
- influenza, covid-19, transportation, health awareness video, Lebanon
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Lebanese American UniversityUniversity, hospital or other
- Study start
- 1 Mar 2026 (estimated)
- Primary completion
- 1 Mar 2027 (estimated)
- Study completion
- 1 Mar 2028 (estimated)
- First posted
- 25 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs). The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against respiratory infectious diseases among public transportation drivers in Lebanon. You will be asked to watch a newly produced health-awareness video, then we will test your knowledge about respiratory infectious diseases , health-risk perceptions, attitude towards vaccination, and cognitive dissonance. Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. The experimental group (n=80) will watch a health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry/analyses. An incentive will be provided.
Detailed description
Background: Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs), elevating health-risk perceptions, and enhancing attitudes towards precautionary measures, as per the Health Belief Model (HBM) and Cognitive Dissonance Theory (CDT).
Aim: The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against RID among public transportation drivers in Lebanon.
Methods: This project will be conducted over three stages and executed over two fiscal years (start date March 2026).
Stage one: Drafting the script of the video is inspired by seven published / unpublished evidence-based studies on public transportation drivers in Lebanon and fourteen studies from international literature. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers.
Stage two: Using a Delphi technique, the script will be revised by a panel of eight experts in public health, infection control, psychology, filmmaking, and public transportation using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. A purposive sampling method will be followed. Once consensus is reached, the video will be produced.
Stage three: Non-blinded, randomized, two-arm controlled trial will be conducted by a group of senior nursing students (minimal risk study). Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. Simple randomization technique will be performed. The experimental group (n=80) will watch the health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry/analyses. An incentive will be provided.
Data analysis: Data will be analyzed using SPSS; IBM (version 30). Knowledge statements will be scored and converted to percentage mean score. Risk perceptions, attitude and dissonance will be scored and converted to mean scores. Between group analyses of mean differences will be tested using student t-test and one way analysis of variance (ANOVA) with post hoc analysis (for normally distributed data) and Kruskall Wallis test with post hoc analysis (for skewed data). Forward stepwise linear regression analyses will be executed. Statistical significance will be at P<0.05 (two sided). Interim analysis will be performed at n=40.
Expected outcomes: Public transportation drivers and users might be unknowingly exposed to RID, so promoting their safety is a priority. When public transportation drivers are exposed to a video on RID, they will gain knowledge about it and demonstrate a positive attitude towards precautionary measures. This video contributes to higher service satisfaction and subsequently higher utilization of the transportation system. Utilizing the public transportation systems reduces street congestions, controls pollution, saves money for users and generates profits for stakeholders. Promoting a safe public transportation system reflects positively on public health, aligns with the CDC mission to control the global spread of diseases and lessens disease burden. Last but not least, health awareness videos are cost effective and they can reach a wider audience.
Ethical considerations: This study will not pose any risk or harm to participants. The video will not contain any material that might offend, insult, degrade, or discriminate against study participants in any way possible. Medical jargon and complex terms will be avoided. The video will be concluded with contact information in case participants decided to consult with experts in the future. Data collectors will be trained on how to remedy their concerns through cognitive behavioral therapy techniques to resolve negative thoughts, guide them on sources of knowledge and places to obtain facemasks, hand sanitizers and vaccines. Last but not least, participants will not be asked for any ID. The decision to participate or not will have no impact on drivers.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- After the video is produced, a non-blinded, randomized, two-arm controlled trial will be conducted. The experimental group will watch the newly produced health-awareness video, whereas the control group will watch a neutral video (raising awareness about traffic signs in Lebanon, https://www.youtube.com/watch?v=hb3107sylj0 ). The participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated.
| Arm | Type | Receives |
|---|---|---|
| Experimental group (n=80) will watch the health-awareness video | Experimental | Other: Health awareness video on precautionary measures against respiratory infectious diseaseThe experimental group will watch the newly produced health-awareness video. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced. |
| control group will watch a neutral video | Active comparator | Other: Health awareness video on precautionary measures against respiratory infectious diseasecontrol group will watch a neutral video (raising awareness about traffic signs in Lebanon, https://www.youtube.com/watch?v=hb3107sylj0 ) |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Public transportation drivers who operate within the Lebanese public transportation system, regardless of their nationality or gender.
Key exclusion criteria (2 listed)
- Commercial drivers (trucks) or others who are not in a daily contact with commuters.
- Drivers who are unwilling to enroll in the study or unable to comprehend written/verbal Arabic language will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health awareness video on precautionary measures against respiratory infectious diseaseDrafting of a narrative blueprint of the script for the health-awareness video is inspired by published and unpublished evidence-based studies previously conducted on public transportation drivers in Lebanon. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced. | Other | Experimental group (n=80) will watch the health-awareness video, control group will watch a neutral video |
Primary outcome
Knowledge
Time frame: 2 months
Knowledge about RID mode of transmission and prevention will be evaluated (Khoury and Salameh 2015, Choucair, El Sawda et al. 2021). The percentage mean of knowledge scores (PMS±SD) will be presented. Higher scores indicate better knowledge. This variable measures the effectiveness of the health awareness video.
Patient Education Materials Assessment Tool - Audiovisual (PEMAT-AV) and • DISCERN tool
Time frame: 5 months
PEMAT-AV systematically evaluates the understandability and actionability of educational materials. Understandability is the viewers' ability to understand the video regardless of their diverse backgrounds and varying levels of health literacy. Actionability is the viewers' ability to identify what they can do based on the information presented in the video regardless of their background and level of health literacy. PEMAT produces separate numeric scores for understandability and actionability. DISCERN: to enable information providers to judge the quality of information about treatment choices. DISCERN facilitates the production of new, high quality, and evidence-based consumer health information. DISCERN became a reliable and valid instrument for judging the quality of written consumer health information.
Health-risk perceptions
Time frame: 2 months
Health-risk perceptions: participants' health-risk perceptions will be evaluated following two dimensions of the HBM that are the perceived susceptibility (2 items) and the perceived severity of RID (3 items) (Adams, Hall et al. 2014).
Attitude towards vaccination
Time frame: 2 months
participants' attitude towards vaccination will be evaluated using three domains of the Vaccination Attitudes Examination (VAX) scale: unexplored side effects of the vaccines (5 statements), pharmaceutical companies profiteering from vaccines (3 statements), and preferred reliance on natural immunity (3 statements). VAX is a generic tool that identifies people with negative attitudes towards vaccines (Martin and Petrie 2017).
Cognitive dissonance
Time frame: 2 months
dissonance is a self-reported measure of the emotional discomfort experienced due to cognitive dissonance (Elliot and Devine 1994). Cognitive dissonance can be measured using the dissonance thermometer that constitutes of adjectives distributed across four indices (discomfort index, negative self-index, shame index, and positive index). All four subscales demonstrated acceptable levels of reliability, with the positive and negative affect scales exhibiting excellent internal consistency and test-retest reliability (McGrath 2011). For this study, the discomfort index that constitutes of uncomfortable, uneasy, and bothered feelings will be used as adjective ratings (0 to 6). Higher score indicates an increased level of discomfort due to the effect of the video content.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Nov 2025.
- Results publicationRisk perceptions towards respiratory infectious diseases among university students utilizing the public transportation system in Lebanon
- Results publication: PubMed 39845631Salam M, Haidar GH. Influenza vaccine hesitancy and its determinants among Lebanese public transportation drivers. Vaccine X. 2024 Dec 25;22:100606. doi: 10.1016/j.jvacx.2024.100606. eCollection 2025 Jan.
- Results publication: PubMed 42627643Salam M, Honein-AbouHaidar G, Abdulrahim S. Exploring the challenges that public transportation drivers face in Lebanon. Work. 2026 Aug 21:10519815261476676. doi: 10.1177/10519815261476676. Online ahead of print.
- Results publicationCOVID-19 risk perceptions among public transportation drivers and users in Lebanon: A cross-sectional study
- Derived from this study: PubMed 42324927Salam M, El Dhaybe S, Ghannam L, Serhan M, Hassan M. Production of a Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases for Public Transportation Drivers: Protocol for a Scoping Review, a Delphi Study, and a Randomized Controlled Trial. JMIR Res Protoc. 2026 Jun 19;15:e89474. doi: 10.2196/89474.
- Individual participant dataSharing planned: Undecided. Sharing of IPD will follow local policies and regulations.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mahmoud Salam, PhD principal investigator
Lebanese American University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Health awareness video on precautionary measures against respiratory infectious disease in people with Produce and Evaluate an Evidence-based Health Awareness Video, run by Lebanese American University at 1 site in Lebanon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mahmoud Salam, PhD (+96170054397, mahmoud.salam@lau.edu.lb), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge (time frame: 2 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07248319, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.